Stocks slide as AI selloff deepens, Asia set for worst week since 2020
Resumen detallado
The MSCI index of Asia-Pacific shares outside Japan tumbled and has sunk 8% this week, its worst performance since the COVID pandemic in March 2020. Nvidia's blowout earnings…
LONDON/HONG KONG/SINGAPORE, Nov 20 (Reuters) - Stock markets stumbled around the world on Friday after Anthropic's IPO failed to restore investors' faith in the AI sector, with Asian shares heading for their worst week since 2020, US futures falling and a gauge of global equities set for its seventh straight daily decline.
Shares of Anthropic, the world's first publicly traded frontier AI company, jumped as it launched the biggest IPO in history on Thursday, although they pared gains later in the session.
The debut did little to revive excitement over the broader AI theme, however, as investors continued to question whether the huge amounts of spending would deliver returns.
"It was far from the euphoria needed to inject new energy into the AI trade," said Johan Javeus, senior economist at Swedish bank SEB.
The STOXX 600 gauge of European stocks fell 1.5% in morning trading, down 5% from a record high on November 12.
MSCI's world index of stocks fell for a seventh straight session, the longest losing streak since 2023.
The MSCI index of Asia-Pacific shares outside Japan tumbled and has sunk 8% this week, its worst performance since the COVID pandemic in March 2020.
Nvidia's blowout earnings earlier in the week and Anthropic's IPO have both failed to restore confidence, said Charu Chanana, chief investment strategist at bank and investment firm Saxo.
"The market is no longer looking for proof of AI demand alone," she said. "It wants evidence that the extraordinary spending across the ecosystem can generate sustainable returns."
Inicio del artículo, extracto de Euronext. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (live.euronext.com)
